SMYD4
Protein-lysine N-methyltransferase SMYD4
Also known as: KIAA1936, SMYD4_HUMAN, ZMYND21
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IYR2
- Gene
- SMYD4
- Ensembl
- ENSG00000186532
- Chromosome
- 17
- Canonical length
- 804 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Vesicles,Cytosol
OverviewNCBI Gene
Predicted to enable histone deacetylase binding activity. Involved in heart development. Predicted to be active in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
804 residues, UniProt reviewed canonical sequence.
>Q8IYR2|SMYD4
1 MDLPVDEWKS YLLQKWASLP TSVQVTISTA ETLRDIFLHS SSLLQPEDEL FLKRLSKGYL
61 VGKDSDAPLF YREEGNKKFQ EKDYTGAAVL YSKGVSHSRP NTEDMSLCHA NRSAALFHLG
121 QYETCLKDIN RAQTHGYPER LQPKIMLRKA ECLVALGRLQ EASQTISDLE RNFTATPALA
181 DVLPQTLQRN LHRLKMKMQE KDSLTESFPA ALAKTLEDAA LREENEQLSN ASSSIGLCVD
241 PLKGRCLVAT KDILPGELLV QEDAFVSVLN PGELPPPHHG LDSKWDTRVT NGDLYCHRCL
301 KHTLATVPCD GCSYAKYCSQ ECLQQAWELY HRTECPLGGL LLTLGVFCHI ALRLTLLVGF
361 EDVRKIITKL CDKISNKDIC LPESNNQVKT LNYGLGESEK NGNIVETPIP GCDINGKYEN
421 NYNAVFNLLP HTENHSPEHK FLCALCVSAL CRQLEAASLQ AIPTERIVNS SQLKAAVTPE
481 LCPDVTIWGV AMLRHMLQLQ CNAQAMTTIQ HTGPKGSIVT DSRQVRLATG IFPVISLLNH
541 SCSPNTSVSF ISTVATIRAS QRIRKGQEIL HCYGPHKSRM GVAERQQKLR SQYFFDCACP
601 ACQTEAHRMA AGPRWEAFCC NSCGAPMQGD DVLRCGSRSC AESAVSRDHL VSRLQDLQQQ
661 VRVAQKLLRD GELERAVQRL SGCQRDAESF LWAEHAVVGE IADGLARACA ALGDWQKSAT
721 HLQRSLYVVE VRHGPSSVEM GHELFKLAQI FFNGFAVPEA LSTIQKAEEV LSLHCGPWDD
781 EIQELQKMKS CLLDLPPTPV GPALLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SMYD4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 13 nTPM
- tongue: 9.5 nTPM
- ovary: 9 nTPM
- blood vessel: 7.9 nTPM
- retina: 7.2 nTPM
- urinary bladder: 7.2 nTPM
Single-cell type
- myonuclei: 79 nCPM
- epididymal basal cells: 60 nCPM
- thymic myoid cells: 56 nCPM
- kupffer cells: 55 nCPM
- epididymal clear cells: 49 nCPM
- ovarian stromal cells: 48 nCPM
Immune cell
- basophil: 12 nTPM
- gdT-cell: 5.1 nTPM
- naive CD8 T-cell: 5 nTPM
- plasmacytoid DC: 4.5 nTPM
- MAIT T-cell: 4.3 nTPM
- memory B-cell: 4.1 nTPM
Brain region
- cerebellum: 26 nTPM
- white matter: 21 nTPM
- cerebral cortex: 19 nTPM
- thalamus: 18 nTPM
- amygdala: 18 nTPM
- pons: 18 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SMYD4.
Disease | ImmuneIEDB
Conditions an epitope on SMYD4 was assayed in.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.08
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.01
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SET domain
- Zinc finger, MYND-type
- Tetratricopeptide-like helical domain superfamily
- SET domain superfamily
- SET domain
- MYND finger
- SMYD4, SET domain
- SET and MYND domain-containing protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SMYD4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SMYD4 as an antibody target. Whether an autoantibody or antibody against SMYD4 could matter depends on whether native SMYD4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SMYD4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SMYD4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...